Spots Global Cancer Trial Database for colon neoplasms
Every month we try and update this database with for colon neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) | NCT00600496 | Breast Cancer Breast Neoplasm... Colon Cancer Colonic Cancer Colon Neoplasms Lung Cancer Melanoma Kidney Cancer | AZD6244 Dacarbazine Erlotinib Docetaxel Temsirolimus | 18 Years - 130 Years | AstraZeneca | |
Health and Employment After Gastro Intestinal Surgery - HEAGIS2 | NCT04466631 | Esophageal Neop... Gastric Neoplas... Colon Neoplasms | 18 Years - | University of Padova | ||
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations | NCT04521686 | Cholangiocarcin... Chondrosarcoma Glioma Any Solid Tumor | LY3410738 Gemcitabine Cisplatin Durvalumab | 18 Years - | Eli Lilly and Company | |
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) | NCT00600496 | Breast Cancer Breast Neoplasm... Colon Cancer Colonic Cancer Colon Neoplasms Lung Cancer Melanoma Kidney Cancer | AZD6244 Dacarbazine Erlotinib Docetaxel Temsirolimus | 18 Years - 130 Years | AstraZeneca | |
AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer | NCT01287130 | Colonic Neoplas... Cancer of the C... Colon Cancer Colon Neoplasms Colonic Cancer | Cetuximab AZD6244 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | NCT02632448 | Solid Tumors Colorectal Canc... Breast Cancer Ovarian Cancer Colon Cancer Rectal Cancer Neoplasms Endometrial Can... Soft Tissue Sar... Triple Negative... Pancreas Cancer Pancreatic Canc... | LY2880070 Gemcitabine | 18 Years - | Esperas Pharma Inc. | |
Full Spectrum vs. Standard Forward-viewing Colonoscopy | NCT02117674 | Colon Neoplasms | standard forwar... full-spectrum c... right colon ret... | 18 Years - 80 Years | Attikon Hospital | |
A Novel Technique of HALS With CME and CVL for RCC | NCT02625272 | Colon Neoplasms | Group A | 18 Years - 80 Years | West China Hospital | |
Audit of Surgery for Colorectal Cancer | NCT04349384 | Rectal Adenocar... Colon Adenocarc... | Colorectal rese... | 18 Years - | Institut National d'Oncologie, Morocco | |
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations | NCT04521686 | Cholangiocarcin... Chondrosarcoma Glioma Any Solid Tumor | LY3410738 Gemcitabine Cisplatin Durvalumab | 18 Years - | Eli Lilly and Company | |
Ultrasound Therapy and Therapeutic Exercise for Chemotherapy Induced Peripheral Neuropathy (CIPN) | NCT02499939 | Colon Neoplasms Colorectal Neop... | Standard Care Ultrasound Ther... | 18 Years - | University of Alberta | |
Palbociclib and Cetuximab in Metastatic Colorectal Cancer | NCT03446157 | Cancer of the C... Colon Cancer Colon Neoplasms Colonic Cancer Neoplasms, Colo... | Cetuximab Palbociclib | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
Ultrasound Therapy and Therapeutic Exercise for Chemotherapy Induced Peripheral Neuropathy (CIPN) | NCT02499939 | Colon Neoplasms Colorectal Neop... | Standard Care Ultrasound Ther... | 18 Years - | University of Alberta | |
Palbociclib and Cetuximab in Metastatic Colorectal Cancer | NCT03446157 | Cancer of the C... Colon Cancer Colon Neoplasms Colonic Cancer Neoplasms, Colo... | Cetuximab Palbociclib | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
Cancer Vaccine Targeting Brachyury Protein in Tumors | NCT01519817 | Neoplasms Malignant Solid... Colon Neoplasms Adenocarcinoma | GI-6301 (Yeast ... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
Ultrasound Therapy and Therapeutic Exercise for Chemotherapy Induced Peripheral Neuropathy (CIPN) | NCT02499939 | Colon Neoplasms Colorectal Neop... | Standard Care Ultrasound Ther... | 18 Years - | University of Alberta | |
Audit of Surgery for Colorectal Cancer | NCT04349384 | Rectal Adenocar... Colon Adenocarc... | Colorectal rese... | 18 Years - | Institut National d'Oncologie, Morocco | |
Fluorescent Evaluation of Colorectal Anastamoses | NCT01424293 | Rectal Neoplasm... Colon Neoplasms Diverticulitis | Indocyanine Gre... The SPY® Intrao... | 18 Years - 100 Years | Maimonides Medical Center | |
Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC) | NCT05250648 | Peritoneal Carc... Colon Cancer | complete cytore... complete cytore... | 18 Years - | Hospital Universitario de Fuenlabrada | |
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
Endocuff-assisted vs. Standard Colonoscopy | NCT02340065 | Colon Neoplasms | standard colono... Endocuff-assist... | 18 Years - 80 Years | Attikon Hospital | |
Multicenter Single-port Colectomy RCT | NCT01480128 | Colon Neoplasms | Single-port Multi-port | 20 Years - 85 Years | The Catholic University of Korea | |
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | NCT02632448 | Solid Tumors Colorectal Canc... Breast Cancer Ovarian Cancer Colon Cancer Rectal Cancer Neoplasms Endometrial Can... Soft Tissue Sar... Triple Negative... Pancreas Cancer Pancreatic Canc... | LY2880070 Gemcitabine | 18 Years - | Esperas Pharma Inc. | |
Precision of Optical Diagnosis in Polyps Between 5-15 mm and Its Implications on Surveillance. A Prospective, Multicenter Study. | NCT04232176 | Colonic Polyps Colon Neoplasms Colon Cancer Serrated Adenom... | 18 Years - 80 Years | University Hospital Virgen de las Nieves | ||
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | NCT02632448 | Solid Tumors Colorectal Canc... Breast Cancer Ovarian Cancer Colon Cancer Rectal Cancer Neoplasms Endometrial Can... Soft Tissue Sar... Triple Negative... Pancreas Cancer Pancreatic Canc... | LY2880070 Gemcitabine | 18 Years - | Esperas Pharma Inc. | |
Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver | NCT00149396 | Colorectal Canc... Liver Neoplasms | NV1020 | 18 Years - | MediGene | |
Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver | NCT00149396 | Colorectal Canc... Liver Neoplasms | NV1020 | 18 Years - | MediGene | |
A Novel Technique of HALS With CME and CVL for RCC | NCT02625272 | Colon Neoplasms | Group A | 18 Years - 80 Years | West China Hospital |